Why Tango Therapeutics (TNGX) Is Poised for a Massive Breakout in 2025
Tango Therapeutics Inc. (NASDAQ: TNGX) is a hidden gem in the biotech sector, and I’m here to make the case for why this stock is a screaming buy right now. Trading at just $3.24 as of June 4, 2025, TNGX has all the makings of a breakout candidate: a promising clinical pipeline, strong analyst support, a solid cash position, and recent catalysts that are starting to turn heads. If you’re a growth investor with an appetite for high-reward opportunities, this stock deserves a spot on your radar. Let’s dive into the reasons why I’m strongly bullish on TNGX. A Precision Oncology Powerhouse with a Game-Changing Pipeline Tango Therapeutics is a clinical-stage biotech company focused on precision oncology, specifically targeting cancers with MTAP deletions—a genetic feature found in a wide range
Broadcom's Moment Under Spotlight : Is A Big Beat on the Horizon?
🌟🌟🌟Broadcom $Broadcom(AVGO)$ is up 3.2% on Tuesday, on pace to set an all time high ahead of its fiscal 2nd quarter results on Thursday. Broadcom's share price has been on a tear. It is up 8% in the past week and 27.9% in just 1 month. In 2024, Broadcom has skyrocketed by 94%. Citi Research's Analyst Christopher Danely expects a strong result and has raised his target price to USD 275 from USD 210, reiterating a Buy Rating, citing strong demand for Broadcom's AI processors. Broadcom has also announced the shipment of its new Tomahawk 6 switch series on Tuesday. The chips, which are designed to handle demand from large AI clusters, will have double the bandwidth of any Ethernet swit
AVGO, HIMS, WMT, V& NVDA Enjoy Great Potential Here!
Hello everyone! Today i want to share some technical analysis with you!1. $NVIDIA(NVDA)$ Q1 2023 Revenue: $7.19B (-13% YoY) $NVIDIA(NVDA)$ Q1 2025 Revenue: $44.06B (+69% YoY)What a difference two years can make. 👑Image2. $Hims & Hers Health Inc.(HIMS)$ finally flashing signs of exhaustion?Up nearly +20% this morning... closed red by the bell. 🥵Image3.Credit Card debt at all-time highs? Party on. 🥳 $Visa(V)$ | $MasterCard(MA)$ Image4. $Wal-Mart(WMT)$ All systems go. 🟢Image5. $Broadcom(AVGO)$ Av-Go
$NVIDIA(NVDA)$$GraniteShares 2x Long NVDA Daily ETF(NVDL)$ 🚀🤖📈 Nvidia’s AI Supremacy: From Blackwell to Rubin, $NVDA Charts a Course Toward $200 📈🤖🚀 Trading like a seasoned Wall Street analyst, I’m captivated by Nvidia’s ($NVDA) trajectory as it carves a path through the complexities of today’s macro backdrop. I entered $NVDA at $141.39 on 3 June 2025, and the setup screams conviction. We’ve already reclaimed the May highs, and with my position up +2.92% unrealised, I believe we’re heading toward $165 short-term and $200 before year-end. Below is my platinum-tier breakdown of why this setup remains one of the most asymmetric opportunities in global equities. 📉 Technical Framework: A Breakout Poised for C
1. $Hims & Hers Health Inc.(HIMS)$ Solid push this morning off news but couldn't hold.We removed our long at the end of May when daily BX flipped 🔴Weekly and Monthly are still showing strength. The daily BX is showing HL for multiple sessions which is first signs of a bounce.I will remain patient and wait for the BX to flip on the daily before going long again ✅Image2. $Robinhood(HOOD)$ We've been bullish for a couple weeks now when the BX flipped 🟢.Weekly BX Bot price explorer is pricing in a move between $80 - $100 before rejection. 🎯On top of that, daily BX could also flip today signaling shorter term strength.Seems there is still some upside for this name going into the summer 😎Image3.
1. $Target(TGT)$ Extreme discount range right now and sitting at our smart money zone 🟣That said, we don't buy just because something is at discount. We NEED to see buyers stepping in first.Best case I enter this next month if we bounce and BX closes HL Image2. $Strategy(MSTR)$ Took profits last month when Daily BX bot closed 💸Weekly still showing strength and the daily is bouncing nicely. BX showing HL two sessions in a row which is an early sign of a bottom ⚠️I will wait for BX to flip 🟢 again to go long. From there, we could see $450 easy 🎯Image3. $SoFi Technologies Inc.(SOFI)$ We nailed the breakout from July 2024 to Jan 2025 — +100% move.Now? I’m keeping this
SPY - The price is starting to depart from this range
$SPDR S&P 500 ETF Trust(SPY)$ : As I mentioned yesterday, the longer the price remains at the current volume shelf, the greater the likelihood it will serve as a launchpad. Indeed, the price is starting to depart from this range.ImagePullbacks continue to be swiftly bought. As soon as the price recovered the central level shared last Friday with subscribers, I posted at 10:30 AM today about the bullish formation. The longer the price consolidates within the current zone, the higher the chances for a new bullish leg increase. The recovery of the 5-day moving average further supports the bullish momentum.ImageFor whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 comm
APLD Hooks CoreWeave and Skyrockets — Should You Join the Party or Stay Cautious?
Shares of Applied Digital ( $APPLIED DIGITAL CORP(APLD)$ ) just pulled off a jaw-dropping 54% surge in a single day, fueled by a massive lease deal with CoreWeave, an Nvidia-backed AI powerhouse. The data-center operator’s 15-year agreement promises a whopping $7 billion in revenue, lighting up the market and sending investors into a frenzy. With the stock closing 48% higher at $10.14 and trading volume shattering records, the buzz is undeniable. But here’s the million-dollar question: Is this your golden ticket to ride APLD to $20, or are you crashing a party that’s already peaked? Let’s break it down. What’s Behind the Hype? Applied Digital isn’t just leasing office space—it’s handing over 250 megawatts (MW) of cutting-edge data center capacity
The Fall of USD: Gold, Stablecoins, and Bitcoin, Who Will Shape the Future?
Against the backdrop of soaring fiscal deficits and persistent inflationary pressures, the U.S. dollar's reign as the world’s reserve currency is facing its most serious challenge in history. Meanwhile, a quiet competition is unfolding among multiple forms of money.1. The Return of Gold: PT to $3700! From Safe-Haven Asset to Legal Tender? Last week, a piece of legislation in Florida brought the long-dormant idea of a gold and silver standard back into the spotlight.The new law formally recognizes gold and silver as legal tender in the state and establishes a legal framework for taxation, custody, and payment. Scheduled to take effect in July 2026, this marks a substantial shift for precious metals from “investment assets” to actual mediums of exchange within the payment system.Florida Gove
$APPLIED DIGITAL CORP(APLD)$ 📊 Key Financial Highlights – Q3 Fiscal Year 2025 (Ended February 28, 2025) 🟦 Revenue Total Revenue: $52.9 million Growth: +22% YoY (vs. $43.3M in Q3 FY2024) Segment Breakdown: Cloud Services: $17.8 million ↑ 220% YoY (from $5.6M) ↓ Sequentially from Q2 FY2025 ($27.7M) due to technical issues & contract model shift Data Center Hosting: $35.2 million ↓ 7% YoY (from $37.8M) HPC Hosting: Revenue not yet recognized (Ellendale build-out still underway) 🟥 Profitability GAAP Net Loss Attributable to Common Stockholders: Q3 FY2025: $36.1 million or $0.16/share Q3 FY2024: $62.8 million or $0.52/share Adjusted Net Loss (Non-GAAP): $17.8 million or $0.08/share Adjusted EBITDA: $10.0 million profit Compared to ($1.
Nancy Pelosi's Tempus' AI Boost: New Product & AI Helpers
$Tempus AI(TEM)$ is up 15% after launching AI agents directly into Electronic Healthcare Records (EHRs).Why did the $Tempus AI(TEM)$ price go up?The new test is a game-changer: Tempus came out with this cool new test called xM. It’s like a super-smart way to monitor how cancer patients are responding to immunotherapy. Instead of waiting for symptoms to show up, doctors can get early insights into what’s happening with the cancer cells just by analyzing a blood sample. This helps them tweak treatments way ahead of time. The market loves this kind of innovation, so investors got excited and the stock price jumped.AI is now in hospitals: Tempus embedded over 1,000 AI helpers directly into hospital electronic heal
Hologic (HOLX) Stock Analysis – A Hidden Gem or Value Trap?
$Hologic(HOLX)$ Today we’re diving into a stock that came in through a viewer request down in the comments—Hologic Inc., ticker symbol HOLX. It's not a name that comes up often, and that’s exactly why it caught my attention. I’ve actually owned this one before, and written about it in the past, but I don’t think I’ve ever covered it in video format. So, now seems like a great time to take a closer look. Who is Hologic? Before we get into numbers and valuation, let’s talk a bit about what Hologic actually does. The company is structured around four key segments, all of which point to a core focus on women’s health: Molecular Diagnostics – This segment is heavily involved in testing for infectious diseases such as HPV, chlamydia, HIV, hepatitis, and
Tesla’s Sales Nosedive: Will Robotaxi Pull It Back from the Brink?
$Tesla Motors(TSLA)$ Tesla’s in a tailspin. A 12.3% plunge in new car registrations in France in May 2025 has sparked alarm bells, while Chinese EV giants like Li Auto, XPeng, and NIO are flexing their muscles with jaw-dropping delivery gains. With Tesla’s stock teetering and its global dominance under threat, all eyes are on the Robotaxi launch slated for June 12 in Austin, Texas. Can this ambitious autonomous venture yank Tesla back from the edge, or is it too little, too late? Let’s unpack the chaos and see what’s really at stake. France’s Cold Shoulder: Tesla’s Sales Hit a Wall Tesla’s May slump in France—down 12.3% in new registrations—isn’t just a hiccup. It’s a red flag waving over a broader struggle. Globally, Tesla’s deliveries dipped 13%
New High Alert: Can Palantir Pull Off Another 2x This Year?
$S&P 500(.SPX)$ Palantir Technologies ( $Palantir Technologies Inc.(PLTR)$ ) has soared to a record high of $134.48, cementing its status as a Wall Street darling. With a 75% year-to-date gain in 2025 and a market cap now hovering at $309 billion, the buzz is electric. Fueling this surge are reports of Palantir engaging with the Social Security Administration (SSA) and the Internal Revenue Service (IRS), alongside its existing $795 million Department of Defense contract. But with a sky-high forward P/E of 222, investors are asking: Can Palantir double again in 2025? Will it reclaim its S&P 500 top-performer crown? And is it still the ultimate pick for the Trump term? Let’s break it down. Palantir’
$VXX 20250606 70.0 CALL$ VXX: collect 2.1% premium for these short calls with strike at $70.Contract expires next week on 6th June.Took opportunity for the spike in volatile to sell few batches of VXX at various strike value and time frame to spread out the risk, all with the intention to collect premium and hope to avoid assignments as these are naked calls. Looking for the volatility to come back down once the trade deals with the few other major US trading partners are completed. If it doesn't, the market would be crashing anyway so the loss is guaranteed.
$NFU.HK 20250529 28.00 PUT$ Held first Nongfu put to expiry. Obtained the premiums and expired worthless. Always happy for such plays because it means that the strategy worked out fine.
$ALB.HK 20250529 70.00 PUT$ Held first BABA put to expiry. Obtained the premiums and expired worthless. Always happy for such plays because it means that the strategy worked out fine.